Neuropsychological Effects of Bilateral Stn Stimulation in Parkinson Disease: a Controlled Study.
From: Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands. h.m.smeding@amc.uva.nl
Neurology
- Publish Date: Jun 2006
- ISSN: 1526-632X
- Volume: 66
- Issue: 12
- Pages: 1830-6
- Medium: Internet
- Language: English
- Citation (JAMA): Smeding H M M, Speelman J D, Koning-Haanstra M, et al. Neuropsychological Effects of Bilateral Stn Stimulation in Parkinson Disease: a Controlled Study.. Neurology Jun 2006;66:1830-6
Abstract
OBJECTIVE: To evaluate the cognitive and behavioral effects of bilateral subthalamic nucleus (STN) stimulation in patients with Parkinson disease (PD). METHODS: The authors included 103 patients; 99 patients were evaluated 6 months after surgery. A control group of 39 patients with PD was formed and 36 patients were evaluated 6 months later. At baseline and at follow-up we administered neuropsychological tests of language, memory, visuospatial function, mental speed, and executive functions. A depression rating scale, a quality of life scale, self and proxy ratings of memory and dysexecutive symptoms, and a neuropsychiatric interview were also administered. RESULTS: Six months after surgery, the STN group showed a larger decline than the control group on measures of verbal fluency, color naming, selective attention, and verbal memory. Moreover, the STN group showed a decrease in positive affect, and an increase in emotional lability and cognitive complaints. On the other hand, the STN group showed an increase in quality of life and a slight decrease in depressive symptoms. Nine percent of the STN patients had psychiatric complications (vs 3% of controls). CONCLUSIONS: Bilateral subthalamic nucleus stimulation has an adverse effect on executive functions with implications for daily life of the patients and their relatives.
Mesh Headings (Keywords): Cognition Disorders, Comorbidity, Deep Brain Stimulation, Female, Humans, Incidence, Male, Middle Aged, Neuropsychological Tests, Outcome Assessment (Health Care), Parkinson Disease, Quality of Life, Risk Assessment, Risk Factors, Subthalamic Nucleus, Treatment Outcome
Check for Full Text / PubMed Unique Identifier (PMID): 16801645
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.